Bellerophon Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Bellerophon Therapeutics, Inc.
CIK #0001600132
EDGAR Form CIK 2011 - 2025
10-K [0001600132]
10-Q [0001600132]
3 [0001600132]
4 [0001600132]
5 [0001600132]
8-K [0001600132]
D [0001600132]
SC 13D [0001600132]
SC 13G [0001600132]
Form 13D/13G Filer Form 13D/13G Subject Filed
Nelson Michael Aaron Bellerophon Therapeutics Inc [2024-03-01]
Lepercq de Neuflize Asset Management LLC Bellerophon Therapeutics Inc [2024-01-26]
Nelson Michael Aaron Bellerophon Therapeutics Inc [2024-01-26]
Janus Henderson Group PLC Bellerophon Therapeutics Inc [2023-05-25]
Tang Capital Partners LP Bellerophon Therapeutics Inc [2023-03-17]
Perceptive Advisors LLC Bellerophon Therapeutics Inc [2023-03-14]
Puissance Life Science Opportunities Fund VI Bellerophon Therapeutics Inc [2020-05-22]
Sabby Management LLC Bellerophon Therapeutics Inc [2020-03-30]
Bellerophon Therapeutics Inc Venrock Healthcare Capital Partners II LP [2017-10-10]
CVI Investments Inc Bellerophon Therapeutics Inc [2017-05-18]
View All
Form 3/4/5 Subject 2011 - 2025
Bellerophon Therapeutics, Inc.
Wang Theodore T
Puissance Life Science Opportunities Fund VI
Puissance Capital Management LP
Puissance Capital Fund (GP) LLC
Kim Bobae
Shah Parag Suresh
Dekker Martin
Bruder Scott P
Teufel Crispin
View All
Terms | Privacy | Guide
tony@aum13f.com